Table 4.

Comparison of the urinary levels (ng/ml) of phthalate metabolites in the NJ study population to US general and female population (NHANES 2001–2002 data)

Metabolites	Subjects	GM	50th	75th	90th	95th
MMP	NJ women	*	<LODa	<LODa	1.47	2.48
	US total	1.15	1.50	3.30	6.00	9.80
	US female	1.13	1.30	3.30	6.40	10.3
MEP	NJ women	135	169	400	721	749
	US total	178	169	465	1230	2500
	US female	174	167	427	1050	1840
MBP	NJ women	15.7	14.8	29.6	48.1	68.9
	US total	18.9	20.4	40.4	73.6	108
	US female	20.2	21.6	46.7	85.0	120
MiBP	NJ women	4.05	4.60	7.48	12.6	13.5
	US total	2.71	2.60	5.70	11.9	17.9
	US female	2.68	2.50	5.70	12.6	18.7
MBzP	NJ women	10.0	9.15	21.4	44.3	52.8
	US total	15.1	15.7	38.0	80.8	122
	US female	14.6	15.4	38.1	81.4	122
MCPP	NJ women	1.63	1.55	3.20	4.17	7.09
	US total	2.75	3.00	5.70	10.0	14.6
	US female	2.62	3.00	5.60	10.0	14.7
MEHP	NJ women	109	115	155	227	246
	US total	4.27	4.10	9.80	22.8	38.9
	US female	4.23	4.10	9.70	23.0	42.5
MEHHP	NJ women	112	109	203	245	309
	US total	20.0	20.1	43.6	91.3	192
	US female	18.3	18.2	39.8	86.0	170
MEOHP	NJ women	93.4	95.1	166	213	233
	US total	13.5	14.0	29.6	59.9	120
	US female	12.5	13.0	28.1	57.5	115

^*Geometric mean not calculated because detection of frequency < 60%.